SCHEMBL5321902

SCHEMBL5321902

CCCNC(O)Cc1ccc(NS(C)(=O)=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.51
▸ LMNA P02545 3/20 0.51
▸ HPGD P15428 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ ADRB2 P07550 5/20 0.47
▸ ADRB1 P08588 5/20 0.47
▸ ADRB3 P13945 4/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ GLA P06280 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ CACNA1F O60840 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ ADRA2B P18089 1/20 0.44
▸ ADRA2C P18825 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7626366 0.99 LMNA (0.50) KDM4ELMNAHPGDALDH1A1HTT
SCHEMBL5317203 0.81 ADRA2A (0.56) ADRB2ADRB1ADRB3ADRA2BADRA2C
SCHEMBL16776722 0.80 LMNA (0.56) KDM4ELMNAHPGDALDH1A1HTT
SCHEMBL21635531 0.80 LMNA (0.56) KDM4ELMNAHPGDALDH1A1HTT
SCHEMBL8213401 0.79 ADRB1 (0.56) HPGDSMN1; SMN2ADRB2ADRB1ADRB3
Hydrochloric Acid SCHEMBL6420499 0.79 LMNA (0.55) KDM4ELMNAHPGDALDH1A1HTT
SCHEMBL9506665 0.76 LMNA (0.59) KDM4ELMNAHPGDALDH1A1HTT
SCHEMBL3336139 0.73 KDM4E (0.73) KDM4ELMNAHPGDALDH1A1HTT
Hydrochloric Acid SCHEMBL8213972 0.72 LMNA (0.50) KDM4ELMNAHPGDALDH1A1HTT
SCHEMBL11251333 0.72 NPC1 (0.48) KDM4ELMNAHPGDALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007087367-A9 METHODS AND COMPOSITIONS FOR MODULATING THE MOBILIZATION OF STEM CELLS SINAI SCHOOL MEDICINE (US) 2007-09-13 — — WO disclosed
WO-2007087367-A2 METHODS AND COMPOSITIONS FOR MODULATING THE MOBILIZATION OF STEM CELLS MOUNT SINAI SCHOOL OF MEDICINE (US) 2007-08-02 — — WO disclosed
EP-1490090-A4 ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS NEW RIVER PHARMACEUTICALS INC (US) 2006-09-20 — — EP disclosed
WO-2005099699-A1 COMBINATION OF (S)-AMLODIPINE AND A BETA-BLOCKER, AND METHODS FOR REDUCING HYPERTENSION SEPRACOR INC. (US) 2005-10-27 — — WO disclosed
EP-1357928-A4 A NOVEL PHARMACEUTICAL COMPOUND AND METHODS OF MAKING AND USING SAME NEW RIVER PHARMACEUTICALS INC (US) 2004-12-29 — — EP disclosed
EP-1490090-A2 ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS New River Pharmaceuticals Inc. (US) 2004-12-29 — — EP disclosed
EP-1357928-A2 A NOVEL PHARMACEUTICAL COMPOUND AND METHODS OF MAKING AND USING SAME New River Pharmaceuticals Inc. (US) 2003-11-05 — — EP disclosed
WO-2003079972-A2 ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS NEW RIVER PARMACEUTICALS INC. (US) 2003-10-02 — — WO disclosed
WO-2003020200-A2 A NOVEL PHARMACEUTICAL COMPOUND AND METHODS OF MAKING AND USING SAME NEW RIVER PHARMACEUTICALS INC. (US) 2003-03-13 — — WO disclosed
EP-1146865-A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF DEXTRO- AND LAEVO- ISOMERS OF SOTALOL Torrent Pharmaceuticals Ltd (IN) 2001-10-24 — — EP disclosed
WO-2000045807-A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF DEXTRO- AND LAEVO- ISOMERS OF SOTALOL SANKARANARAYANAN ALANGUDI (IN) 2000-08-10 — — WO disclosed
Send feedback